OverviewSuggest Edit

NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society. NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand. NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation. NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
TypePublic
HQAshford, GB
Websitenetscientific.net

Recent NewsAll News

Latest Updates

Employees (est.) (Jul 2021)13
Revenue (FY, 2018)£245 K(+44%)
Share Price (Oct 2021)£1.1(+2%)
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Netscientific

Larry Cohen

Larry Cohen

CEO of Glycotest
Ilian Iliev

Ilian Iliev

Chief Executive Officer
David Ribeiro

David Ribeiro

CEO of ProAxsis
John Clarkson

John Clarkson

Executive Chairman
Frank K. Bedu-Addo

Frank K. Bedu-Addo

CEO of PDS Biotechnology
Clive Sparrow

Clive Sparrow

Non-Executive Director
Show more

Netscientific Office Locations

Netscientific has an office in Ashford
Show all (1)

Netscientific Financials and Metrics

Netscientific Revenue

Netscientific's revenue was reported to be £245 k in FY, 2018
GBP

Revenue (FY, 2018)

245.0k

Gross profit (FY, 2018)

167.0k

Gross profit margin (FY, 2018), %

68.2%

Net income (FY, 2018)

(4.0m)

EBITDA (FY, 2018)

(3.3m)

EBIT (FY, 2018)

(4.1m)

Market capitalization (22-Oct-2021)

16.1m

Closing stock price (22-Oct-2021)

1.1

Cash (31-Dec-2018)

2.9m
Netscientific's current market capitalization is £16.1 m.
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

16.0k177.7k21.0k518.0k171.0k245.0k

Revenue growth, %

274%559%

Cost of goods sold

6.0k255.0k80.0k78.0k

Gross profit

15.0k263.0k91.0k167.0k
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

410.8k25.5m16.9m23.2m9.5m6.9m2.9m

Accounts Receivable

260.057.3k37.0k109.0k115.0k112.0k

Inventories

86.0k37.0k

Current Assets

632.4k25.9m17.7m23.8m11.0m8.0m4.2m
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(1.5m)(4.3m)(6.2m)(10.4m)(12.4m)(4.2m)(4.0m)

Cash From Operating Activities

(1.2m)(3.7m)(6.6m)(10.6m)(12.8m)(10.6m)(8.3m)

Cash From Financing Activities

861.5k28.9m190.0k17.2m70.0k7.5m4.7m

Net Change in Cash

(393.3k)25.1m(8.8m)6.2m(14.4m)(2.2m)(3.7m)
GBPFY, 2012

Debt/Equity

-1 x

Debt/Assets

4.4 x

Financial Leverage

-0.2 x
Show all financial metrics

Netscientific Online and Social Media Presence

Embed Graph

Netscientific News and Updates

Netscientific Blogs

EMV Capital Participates in £843k Sofant Funding

NetScientific plc (“NetScientific”, the “Group” or the “Company”) EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer Sofant Technologies   London, UK – 26 October 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability techno…

EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer Sofant Technologies

NetScientific plc (“NetScientific”, the “Group” or the “Company”) EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer Sofant Technologies   London, UK – 26 October 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability techno…

ProAxsis announces the approval of a key US patent

NetScientific plc (“NetScientific”, the “Group” or the “Company”) ProAxsis announces the approval of a key US patent   ProAxsis makes significant progress towards measuring bone health with a new innovation for patients at high risk of osteoporotic fractures     London, UK – 22 October 2021 – NetSci…

ProAxsis makes significant progress towards measuring bone health with a new innovation for patients at high risk of osteoporotic fractures

ProAxsis is delighted to announce the approval of a key US patent for the underlying technology associated with its brand-new K-POSTN Assay, which the company intends to launch shortly. In partnership with the expert Bone Health team led by Professor Serge Ferrari at the University of Geneva, ProAxs…

ProAxsis presents its new NEATstik lateral flow test for lung infections at the Respiratory Professional Care Exhibition in Birmingham

ProAxsis, one of NetScientific’s portfolio companies specialized in the Life Sciences sector, has just presented its new NEATstik product which has been specially developed to make an immediate difference in respiratory management, at the UK’s Respiratory Professional Care Exhibition in Birmingham, …

PDS Phase 2 Clinical Trial Update

NetScientific plc (“NetScientific”, the “Group” or the “Company”) PDS Phase 2 Clinical Trial Update   PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase 2 Clinical Trial in Advanced HPV-16 Positive Head and Neck Cancer     London, UK – 05 October 2021 – NetScientific …
Show more

Netscientific Frequently Asked Questions

  • Who are Netscientific key executives?

    Netscientific's key executives are Larry Cohen, Ilian Iliev and David Ribeiro.

  • How many employees does Netscientific have?

    Netscientific has 13 employees.

  • What is Netscientific revenue?

    Latest Netscientific annual revenue is £245 k.

  • What is Netscientific revenue per employee?

    Latest Netscientific revenue per employee is £18.8 k.

  • Who are Netscientific competitors?

    Competitors of Netscientific include St. Charles Health System, HSJL and Radiology Partners.

  • Where are Netscientific offices?

    Netscientific has an office in Ashford.

  • How many offices does Netscientific have?

    Netscientific has 1 office.